Literature DB >> 8490182

Mechanisms for actin reorganization in chemotactic factor-activated polymorphonuclear leukocytes.

R G Watts1, T H Howard.   

Abstract

Cytoskeletal structure in polymorphonuclear leukocytes (PMNs) is thought to reflect a simple equilibrium between two actin pools (globular [G]- and filamentous [F] actin). Recent description of two distinct F-actin pools in PMNs (Triton-insoluble [stable] and Triton-soluble [labile] F-actin pools) (Watts and Howard, Cell Motil Cytoskeleton, 21:25, 1992) suggest a tripartite equilibrium between these F-actin pools and G-actin and multiple possible mechanisms for polymerization. To study the contribution of each actin pool to actin dynamics in PMNs, changes in actin content of the Triton-soluble and -insoluble F-actin pools and G-actin in chemotactic factor (CTF)-activated PMNs were measured by NBDphallacidin binding and by gel scans of Triton-lysed PMNs. From 0 to 30 seconds after CTF activation, PMNs rapidly increase total (Triton-soluble + Triton-insoluble) F-actin content (maximum = 1.7- +/- 0.10-fold basal at 30 seconds). Concurrent measures of the actin content of individual actin pools (Triton-soluble and -insoluble F-actin and G-actin) show that at all times (0 to 30 seconds) only the Triton-insoluble F-actin pool grows (maximum = 2.81- +/- 0.73-fold basal at 30 seconds), whereas both the Triton-soluble and G-actin pools simultaneously decrease (50% decrease at 30 seconds). Concurrent growth of one F-actin pool (Triton-insoluble) and loss of another F-actin pool (Triton-soluble) emphasize the functional uniqueness of the F-actin pools and can occur only if the Triton-soluble F-actin anneals or cross-links filament-to-filament with the Triton-insoluble fraction or if the Triton-insoluble F-actin pool first depolymerizes to monomer, which is then added to the Triton-insoluble pool. Because from 0 to 30 seconds after FMLP activation G-actin never increases, but, like the Triton-soluble F-actin progressively decreases, the results suggest that F-actin growth results from simultaneous new filament growth by monomer addition to the Triton-insoluble F-actin and cytoskeletal remodelling by Triton-soluble F-actin annealing or cross-linking to Triton-insoluble F-actin. These findings offer important new insights into the mechanism(s) of actin polymerization in CTF-activated human PMNs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8490182

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  The mechanics of neutrophils: synthetic modeling of three experiments.

Authors:  Marc Herant; William A Marganski; Micah Dembo
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

2.  The beta2, alpha4, alpha5 integrins and selectins mediate chemotactic factor and endotoxin-enhanced neutrophil sequestration in the lung.

Authors:  J A Burns; T B Issekutz; H Yagita; A C Issekutz
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

3.  2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells.

Authors:  Maiko Gokoh; Seishi Kishimoto; Saori Oka; Masahiro Mori; Keizo Waku; Yoshio Ishima; Takayuki Sugiura
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

4.  Actin Turnover in Lamellipodial Fragments.

Authors:  Dikla Raz-Ben Aroush; Noa Ofer; Enas Abu-Shah; Jun Allard; Oleg Krichevsky; Alex Mogilner; Kinneret Keren
Journal:  Curr Biol       Date:  2017-09-28       Impact factor: 10.834

5.  Activation of protein kinase C in rat basophilic leukemia cells stimulates increased production of phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate: correlation with actin polymerization.

Authors:  J R Apgar
Journal:  Mol Biol Cell       Date:  1995-01       Impact factor: 4.138

6.  Actin-Resistant DNase1L2 as a Potential Therapeutics for CF Lung Disease.

Authors:  Danila Delfino; Giulia Mori; Claudio Rivetti; Antonella Grigoletto; Gloria Bizzotto; Cristian Cavozzi; Marco Malatesta; Davide Cavazzini; Gianfranco Pasut; Riccardo Percudani
Journal:  Biomolecules       Date:  2021-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.